243 related articles for article (PubMed ID: 20797753)
1. Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice.
Jabbar S; Strati K; Shin MK; Pitot HC; Lambert PF
Virology; 2010 Nov; 407(1):60-7. PubMed ID: 20797753
[TBL] [Abstract][Full Text] [Related]
2. Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model.
Strati K; Pitot HC; Lambert PF
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14152-7. PubMed ID: 16959885
[TBL] [Abstract][Full Text] [Related]
3. Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins.
Buonomo T; Carraresi L; Rossini M; Martinelli R
J Transl Med; 2011 Jan; 9():2. PubMed ID: 21205295
[TBL] [Abstract][Full Text] [Related]
4. ErbB-2 receptor cooperates with E6/E7 oncoproteins of HPV type 16 in breast tumorigenesis.
Yasmeen A; Bismar TA; Dekhil H; Ricciardi R; Kassab A; Gambacorti-Passerini C; Al Moustafa AE
Cell Cycle; 2007 Dec; 6(23):2939-43. PubMed ID: 18156804
[TBL] [Abstract][Full Text] [Related]
5. Pocket proteins suppress head and neck cancer.
Shin MK; Pitot HC; Lambert PF
Cancer Res; 2012 Mar; 72(5):1280-9. PubMed ID: 22237625
[TBL] [Abstract][Full Text] [Related]
6. Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells.
Kahue CN; Jerrell RJ; Parekh A
Cancer Rep (Hoboken); 2018 Oct; 1(3):e1125. PubMed ID: 32721084
[TBL] [Abstract][Full Text] [Related]
7. A novel function of HPV16-E6/E7 in epithelial-mesenchymal transition.
Jung YS; Kato I; Kim HR
Biochem Biophys Res Commun; 2013 Jun; 435(3):339-44. PubMed ID: 23628416
[TBL] [Abstract][Full Text] [Related]
8. A mouse model for human anal cancer.
Stelzer MK; Pitot HC; Liem A; Schweizer J; Mahoney C; Lambert PF
Cancer Prev Res (Phila); 2010 Dec; 3(12):1534-41. PubMed ID: 20947489
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus type 16 E6/E7 upregulation of nucleophosmin is important for proliferation and inhibition of differentiation.
McCloskey R; Menges C; Friedman A; Patel D; McCance DJ
J Virol; 2010 May; 84(10):5131-9. PubMed ID: 20237089
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV
Brand TM; Hartmann S; Bhola NE; Peyser ND; Li H; Zeng Y; Isaacson Wechsler E; Ranall MV; Bandyopadhyay S; Duvvuri U; LaVallee TM; Jordan RCK; Johnson DE; Grandis JR
Clin Cancer Res; 2017 Jun; 23(12):3072-3083. PubMed ID: 27986750
[No Abstract] [Full Text] [Related]
11. A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors.
Wieking BG; Vermeer DW; Spanos WC; Lee KM; Vermeer P; Lee WT; Xu Y; Gabitzsch ES; Balcaitis S; Balint JP; Jones FR; Lee JH
Cancer Gene Ther; 2012 Oct; 19(10):667-74. PubMed ID: 22918471
[TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line.
Harris M; Wang XG; Jiang Z; Goldberg GL; Casadevall A; Dadachova E
Head Neck Oncol; 2011 Feb; 3(1):9. PubMed ID: 21314983
[TBL] [Abstract][Full Text] [Related]
14. mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.
Callejas-Valera JL; Iglesias-Bartolome R; Amornphimoltham P; Palacios-Garcia J; Martin D; Califano JA; Molinolo AA; Gutkind JS
Carcinogenesis; 2016 Oct; 37(10):1014-25. PubMed ID: 27538837
[TBL] [Abstract][Full Text] [Related]
15. Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells.
Boulenouar S; Weyn C; Van Noppen M; Moussa Ali M; Favre M; Delvenne PO; Bex F; Noël A; Englert Y; Fontaine V
Carcinogenesis; 2010 Mar; 31(3):473-80. PubMed ID: 19917629
[TBL] [Abstract][Full Text] [Related]
16. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
Harden ME; Prasad N; Griffiths A; Munger K
mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
[TBL] [Abstract][Full Text] [Related]
17. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
18. Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells.
Bristol ML; James CD; Wang X; Fontan CT; Morgan IM
mSphere; 2020 Mar; 5(2):. PubMed ID: 32188745
[TBL] [Abstract][Full Text] [Related]
19. Loss of Function of Canonical Notch Signaling Drives Head and Neck Carcinogenesis.
Nyman PE; Buehler D; Lambert PF
Clin Cancer Res; 2018 Dec; 24(24):6308-6318. PubMed ID: 30087145
[TBL] [Abstract][Full Text] [Related]
20. [Molecular basis of cervical carcinogenesis by high-risk human papillomaviruses].
Yugawa T; Kiyono T
Uirusu; 2008 Dec; 58(2):141-54. PubMed ID: 19374192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]